Q Question: Write a 300 words discussion to analyse the recent mishaps encountered by Celgene in the past two years and compile the same in the final project paper.
Solution: Despite Celgene’s strong governance ethics and a singular mission for improving the lives of millions, its shares have drastically declined after October 2017 since the failure of a medical trial to cure Crohn’s disease. It had pioneered a new strategy by introducing drugs to the market relies profoundly on partnering with the new companies. But that is not what always happens in reality. Mongersen, a treatment that was devised to treat Crohn’s disease potentially failed in its trial period of Phase II.
